Drug Topics May 7, 2024
As medication experts, pharmacists can advocate to organizational decision makers around the benefits of biosimilars.
Fran Gregory, Vice President of Emerging Therapies at Cardinal Health, sat down with Drug Topics at AXS24, the Asembia Specialty Pharmacy Summit, to discuss the role of pharmacists in improving biosimilar uptake and advocating for health system sustainability.
Drug Topics: As important members of the patient care team, what role can pharmacists play in implementing or improving biosimilar uptake?
Gregory: As a pharmacist myself, obviously I think our role is critical in ensuring uptake of biosimilars in a few areas, really.
Number 1 would be education: Making sure that you are educated on biosimilars, that you know what resources to use to educate yourself on...